<B>Lenalidomide (Revlimid)</B> Lenalidomide is approved for treating lower-risk transfusion-dependent MDS in patients with isolated deletion 5q whether or not tests show they have other abnormal chromosomes. It is a capsule you take by mouth and it can be taken at home. Researchers are not sure exactly how lenalidomide treats MDS.